Adonis Sfera

Publications

• Review Article   
  A Novel Intervention for Long COVID: The Combination of Dopamine D1 Partial Agonists and Candesartan
  Author(s): Adonis Sfera*, Jacob Anton and Sabine Hazan
  
  Like previous pandemics, COVID-19 has been succeeded by well-documented postinfectious sequelae, colloquially known as “long COVID”. This syndrome, manifested by chronic fatigue, post-exertional malaise, shortness of breath, myalgia, and concentration difficulties, may last for many months after the acute phase of illness. Long COVID affects all aspects of a patient’s life, including work, rest, and activities of daily living, placing a large financial burden not only on the individual but also on families, and the society at large. Like other viruses, including Human Immunodeficiency Virus (HIV), Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) may thrive in viral reservoirs, likely comprised of senescent endothelial cells, macrophages, and microglia that shield the virus from neutralizing antibodies, maintaining a low-.. Read More»
  

  Abstract HTML PDF